Following this theme, Hutton et al used a combination of mass cytometry and transcript analysis to identify CD105 as a key CAF lineage marker defining tumour suppressive CAFs (CD105neg), which act by supporting antitumour immunity [64]. This evidence concerns the gene ENG and neoplasm.